Form Type: 4

SEC EDGAR Link
Accession Number:0001104659-19-047563
Date:2019-08-23
Issuer: RA PHARMACEUTICALS, INC. (RARX)
Original Submission Date:

Reporting Person:

RICARDO ALONSO
C/O RA PHARMACEUTICALS, INC.
87 CAMBRIDGEPARK DRIVE CAMBRIDGE, MA 02140

Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
Title of SecurityTransaction Date2a. Deemed Execution Date Transaction CodeSharesAcquired or DisposedPrice per share 5. Amount of Securities Beneficially Owned Following Reported Transaction 6. Ownership Form Direct or IndirectNature of Indirect Ownership
COMMON STOCK 2019-08-23 S 2,285 d $27.89 9,143 direct
Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, convertible securities
Title of Derivative Security Conversion or Exercise Price of Derivative Security Transaction Date Deemed Execution Date Transaction Code Number of Derivative Securities Acquired (A) or Disposed of (D) Date ExercisableExpiration Date Title and Amount of Securities Underlying Derivative Security Price of Derivative Security Number of derivative Securities Beneficially Owned Following Reported Transaction(s) Ownership Form: Direct (D) or Indirect (I) Nature of Indirect Beneficial Ownership
Footnotes
IDfootnote
f1 the sale reported in the form 4 was effected pursuant to a rule 10b5-1 trading plan adopted by the reporting person on may 21, 2019.
f2 the price reported is a weighted average price. the shares were sold in multiple transactions at per share prices ranging from $27.49 to $28.39. the reporting person undertakes to provide upon request to the sec staff, the issuer, or any stockholder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
WhaleWisdom Logo

Elevate your investments